Cargando…

Canine Mammary Tumor Cell Lines Derived from Metastatic Foci Show Increased RAD51 Expression but Diminished Radioresistance via p21 Inhibition

SIMPLE SUMMARY: Canines have a high incidence of mammary tumors, which is a major problem in the veterinary field. Approximately half of canine mammary tumors are malignant and metastasize to nearby lymph nodes. In this study, we analyzed the expression levels of RAD51, a DNA homologous recombinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimakawa, Kei, Ochiai, Kazuhiko, Hirose, Sachi, Tanabe, Eri, Michishita, Masaki, Sakaue, Motoharu, Yoshikawa, Yasunaga, Morimatsu, Masami, Tajima, Tsuyoshi, Watanabe, Masami, Tanaka, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784702/
https://www.ncbi.nlm.nih.gov/pubmed/36548864
http://dx.doi.org/10.3390/vetsci9120703
_version_ 1784857872517038080
author Shimakawa, Kei
Ochiai, Kazuhiko
Hirose, Sachi
Tanabe, Eri
Michishita, Masaki
Sakaue, Motoharu
Yoshikawa, Yasunaga
Morimatsu, Masami
Tajima, Tsuyoshi
Watanabe, Masami
Tanaka, Yoshikazu
author_facet Shimakawa, Kei
Ochiai, Kazuhiko
Hirose, Sachi
Tanabe, Eri
Michishita, Masaki
Sakaue, Motoharu
Yoshikawa, Yasunaga
Morimatsu, Masami
Tajima, Tsuyoshi
Watanabe, Masami
Tanaka, Yoshikazu
author_sort Shimakawa, Kei
collection PubMed
description SIMPLE SUMMARY: Canines have a high incidence of mammary tumors, which is a major problem in the veterinary field. Approximately half of canine mammary tumors are malignant and metastasize to nearby lymph nodes. In this study, we analyzed the expression levels of RAD51, a DNA homologous recombination repair-related molecule, in canine mammary tumor cell lines derived from the primary tumor CHMp and metastatic tumor CHMm, which were established from the same individual. The RAD51 expression level in CHMm was higher than that in CHMp. However, CHMp was more resistant than CHMm to irradiation and formed functional Rad51 foci, which form at DNA lesions for homologous recombination repair. The cell cycle regulator p21 was expressed upon radiation exposure in CHMp cells, but not in CHMm cells, indicating that CHMm did not induce cell cycle arrest after irradiation. These results suggest that the radioresistance of CHMm, with high RAD51 expression, is lower than that of CHMp. ABSTRACT: Due to the high incidence of mammary tumors in dogs, it is important to elucidate the pathogenesis of these tumors in veterinary medicine. Radiation therapy is often used to treat mammary tumors that target DNA lesions. RAD51 is a key molecule that repairs DNA damage via homologous recombination. We examined the relationship between RAD51 expression and radiosensitivity in mammary tumor cell lines. CHMp and CHMm from the same individual were selected based on the differences in RAD51 expression. The radiosensitivity of both cell lines was examined using MTT and scratch assays; CHMm, which has high RAD51 expression, showed higher sensitivity to radiation than CHMp. However, the nuclear focus of RAD51 during DNA repair was formed normally in CHMp, but not in most of CHMm. Since irradiation resulted in the suppression of cell cycle progression in CHMp, the expression of p21, a cell cycle regulatory factor, was detected in CHMp after 15 Gy irradiation but not in CHMm. These results indicate that functional expression is more important than the quantitative expression of RAD51 in canine mammary tumor cells in response to DNA damage.
format Online
Article
Text
id pubmed-9784702
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97847022022-12-24 Canine Mammary Tumor Cell Lines Derived from Metastatic Foci Show Increased RAD51 Expression but Diminished Radioresistance via p21 Inhibition Shimakawa, Kei Ochiai, Kazuhiko Hirose, Sachi Tanabe, Eri Michishita, Masaki Sakaue, Motoharu Yoshikawa, Yasunaga Morimatsu, Masami Tajima, Tsuyoshi Watanabe, Masami Tanaka, Yoshikazu Vet Sci Article SIMPLE SUMMARY: Canines have a high incidence of mammary tumors, which is a major problem in the veterinary field. Approximately half of canine mammary tumors are malignant and metastasize to nearby lymph nodes. In this study, we analyzed the expression levels of RAD51, a DNA homologous recombination repair-related molecule, in canine mammary tumor cell lines derived from the primary tumor CHMp and metastatic tumor CHMm, which were established from the same individual. The RAD51 expression level in CHMm was higher than that in CHMp. However, CHMp was more resistant than CHMm to irradiation and formed functional Rad51 foci, which form at DNA lesions for homologous recombination repair. The cell cycle regulator p21 was expressed upon radiation exposure in CHMp cells, but not in CHMm cells, indicating that CHMm did not induce cell cycle arrest after irradiation. These results suggest that the radioresistance of CHMm, with high RAD51 expression, is lower than that of CHMp. ABSTRACT: Due to the high incidence of mammary tumors in dogs, it is important to elucidate the pathogenesis of these tumors in veterinary medicine. Radiation therapy is often used to treat mammary tumors that target DNA lesions. RAD51 is a key molecule that repairs DNA damage via homologous recombination. We examined the relationship between RAD51 expression and radiosensitivity in mammary tumor cell lines. CHMp and CHMm from the same individual were selected based on the differences in RAD51 expression. The radiosensitivity of both cell lines was examined using MTT and scratch assays; CHMm, which has high RAD51 expression, showed higher sensitivity to radiation than CHMp. However, the nuclear focus of RAD51 during DNA repair was formed normally in CHMp, but not in most of CHMm. Since irradiation resulted in the suppression of cell cycle progression in CHMp, the expression of p21, a cell cycle regulatory factor, was detected in CHMp after 15 Gy irradiation but not in CHMm. These results indicate that functional expression is more important than the quantitative expression of RAD51 in canine mammary tumor cells in response to DNA damage. MDPI 2022-12-17 /pmc/articles/PMC9784702/ /pubmed/36548864 http://dx.doi.org/10.3390/vetsci9120703 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shimakawa, Kei
Ochiai, Kazuhiko
Hirose, Sachi
Tanabe, Eri
Michishita, Masaki
Sakaue, Motoharu
Yoshikawa, Yasunaga
Morimatsu, Masami
Tajima, Tsuyoshi
Watanabe, Masami
Tanaka, Yoshikazu
Canine Mammary Tumor Cell Lines Derived from Metastatic Foci Show Increased RAD51 Expression but Diminished Radioresistance via p21 Inhibition
title Canine Mammary Tumor Cell Lines Derived from Metastatic Foci Show Increased RAD51 Expression but Diminished Radioresistance via p21 Inhibition
title_full Canine Mammary Tumor Cell Lines Derived from Metastatic Foci Show Increased RAD51 Expression but Diminished Radioresistance via p21 Inhibition
title_fullStr Canine Mammary Tumor Cell Lines Derived from Metastatic Foci Show Increased RAD51 Expression but Diminished Radioresistance via p21 Inhibition
title_full_unstemmed Canine Mammary Tumor Cell Lines Derived from Metastatic Foci Show Increased RAD51 Expression but Diminished Radioresistance via p21 Inhibition
title_short Canine Mammary Tumor Cell Lines Derived from Metastatic Foci Show Increased RAD51 Expression but Diminished Radioresistance via p21 Inhibition
title_sort canine mammary tumor cell lines derived from metastatic foci show increased rad51 expression but diminished radioresistance via p21 inhibition
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784702/
https://www.ncbi.nlm.nih.gov/pubmed/36548864
http://dx.doi.org/10.3390/vetsci9120703
work_keys_str_mv AT shimakawakei caninemammarytumorcelllinesderivedfrommetastaticfocishowincreasedrad51expressionbutdiminishedradioresistanceviap21inhibition
AT ochiaikazuhiko caninemammarytumorcelllinesderivedfrommetastaticfocishowincreasedrad51expressionbutdiminishedradioresistanceviap21inhibition
AT hirosesachi caninemammarytumorcelllinesderivedfrommetastaticfocishowincreasedrad51expressionbutdiminishedradioresistanceviap21inhibition
AT tanabeeri caninemammarytumorcelllinesderivedfrommetastaticfocishowincreasedrad51expressionbutdiminishedradioresistanceviap21inhibition
AT michishitamasaki caninemammarytumorcelllinesderivedfrommetastaticfocishowincreasedrad51expressionbutdiminishedradioresistanceviap21inhibition
AT sakauemotoharu caninemammarytumorcelllinesderivedfrommetastaticfocishowincreasedrad51expressionbutdiminishedradioresistanceviap21inhibition
AT yoshikawayasunaga caninemammarytumorcelllinesderivedfrommetastaticfocishowincreasedrad51expressionbutdiminishedradioresistanceviap21inhibition
AT morimatsumasami caninemammarytumorcelllinesderivedfrommetastaticfocishowincreasedrad51expressionbutdiminishedradioresistanceviap21inhibition
AT tajimatsuyoshi caninemammarytumorcelllinesderivedfrommetastaticfocishowincreasedrad51expressionbutdiminishedradioresistanceviap21inhibition
AT watanabemasami caninemammarytumorcelllinesderivedfrommetastaticfocishowincreasedrad51expressionbutdiminishedradioresistanceviap21inhibition
AT tanakayoshikazu caninemammarytumorcelllinesderivedfrommetastaticfocishowincreasedrad51expressionbutdiminishedradioresistanceviap21inhibition